Bowhead Specialty Holdings Inc. (NYSE: BOW), a growing specialty
lines insurance group focused on providing casualty, professional
liability and healthcare liability insurance products, today
announced financial results for the second quarter ended June 30,
2024*.
Second Quarter 2024 Highlights
- Gross written premiums increased 50.4% to $175.5 million.
- Net income of $5.5 million, or $0.20 per diluted share.
- Adjusted net income(1) of $7.9 million, or $0.28 per diluted
share(1).
- Return on equity of 8.2% and adjusted return on equity(1) of
11.7%.
- Upsized initial public offering completed in May 2024, raising
$131.0 million in net proceeds through the issuance of 8,658,823
shares of common stock at $17.00 per share.
___________________
(1) Non-GAAP financial measure.
See “—Reconciliation of Non-GAAP Financial Measures” for a
reconciliation of the non-GAAP financial measures to their most
directly comparable U.S. GAAP measures.
Bowhead Chief Executive Officer Stephen Sills commented, “We are
very pleased with what we have to report for the results of our
first quarter as a publicly traded company. We opened our doors for
business as a specialty insurance underwriter in November of 2020.
Over the next three plus years, we assembled a great team of over
200 employees to get us to where we are today. In May of this year,
we launched an IPO to raise $100 million, which was ultimately
upsized to $131 million in net proceeds. We’ve achieved our
position of prominence in the specialty insurance space by building
a highly experienced team focused on underwriting profitability
through market cycles. We continue to believe we can attract high
quality talent and generate profitable business.”
Mr. Sills continued, “Those that followed us through the IPO
process will recall that almost 80% of our business is in the
E&S market. The favorable market dynamics we saw then still
exist today. In fact, because of the ongoing deteriorating loss
experience in certain sectors and the market’s resulting need to
reprice risks, we see lasting tailwinds for Bowhead, which is free
of these legacy risks.”
Underwriting Results
The 50.4% increase in gross written premiums to $175.5 million
in the second quarter of 2024 was driven by new business, renewals
and continued growth in our platform across all divisions:
- Our Casualty division led the growth with a 78.8% increase to
$114.2 million;
- Healthcare increased 46.4% over the same period to $16.9
million; and
- Professional Liability increased 7.5% to $44.4 million.
- Late in the second quarter of 2024, we launched a new division
called Baleen, which focuses on small, hard-to-place risks written
100% on a non-admitted basis. Baleen is a streamlined, low touch
“flow” underwriting operation that supplements the “craft”
solutions we offer today. In line with our deliberate, measured and
limited roll out, Baleen gross written premiums for the second
quarter of 2024 was minimal. We will report Baleen’s first full
quarter gross written premiums during our third quarter earnings
call.
Our loss ratio of 65.5% in the second quarter of 2024 utilizes
the same industry loss ratios used since the fourth quarter of 2023
and remained unchanged compared to the first quarter of 2024. There
were no changes to loss picks or prior year reserves during the
quarter. As of June 30, 2024, incurred but not reported liabilities
comprised 92.0% of our net loss reserves.
Our expense ratio of 33.8% included $1.3 million of remaining
stock-based compensation costs associated with management’s profit
interest through operating expenses. Excluding this one-time
increase in operating expenses, our expense ratio for the second
quarter of 2024 would be 32.3%, a decrease compared to our first
quarter of 2024 expense ratio of 32.6%.
Investment Results
Net investment income was $8.8 million, driven by the increase
in our investment portfolio and higher yields on invested assets.
Our investment portfolio included $131.0 million of net proceeds
from our IPO, which were not invested for the full quarter.
Excluding the net proceeds from our IPO, our investment portfolio
had a book yield of 4.6% and our new money rate was 5.5% at the end
of the quarter.
Excluding the net proceeds from our IPO, the weighted average
effective duration of our investment portfolio, which included cash
equivalents, increased from 1.9 years at March 31, 2024 to 2.1
years at June 30, 2024, and had an average rating of “AA” at June
30, 2024.
___________________
* Comparisons in this release are made to
June 30, 2023 financial results unless otherwise noted.
Summary of Operating Results
The following table summarizes the Company’s results of
operations for the three months ended June 30, 2024 and 2023:
Three Months Ended June
30,
2024
2023
$ Change
% Change
($ in thousands, except
percentages and per share data)
Gross written premiums
$
175,539
$
116,742
$
58,797
50.4 %
Ceded written premiums
(63,486)
(40,310)
(23,176)
57.5 %
Net written premiums
$
112,053
$
76,432
$
35,621
46.6 %
Revenues
Net earned premiums
$
90,087
$
61,374
$
28,713
46.8 %
Net investment income
8,777
4,048
4,729
116.8 %
Net realized investment gains
2
—
2
NM
Other insurance-related income
32
31
1
4.8 %
Total revenues
98,898
65,453
33,445
51.1 %
Expenses
Net losses and loss adjustment
expenses
59,018
37,409
21,609
57.8 %
Net acquisition costs
7,582
4,960
2,622
52.9 %
Operating expenses
22,855
14,616
8,239
56.4 %
Non-operating expenses
1,481
—
1,481
NM
Warrant expense
332
—
332
NM
Credit facility interest expenses and
fees
224
—
224
NM
Foreign exchange (gains) losses
(4)
8
(12)
(148.5) %
Total expenses
91,488
56,993
34,495
60.5 %
Income before income taxes
7,410
8,460
(1,050)
(12.4) %
Income tax expense
(1,877)
(1,905)
28
(1.5) %
Net income
$
5,533
$
6,555
$
(1,022)
(15.6) %
Key Operating and Financial
Metrics:
Adjusted net income(1)
$
7,880
$
6,561
$
1,319
20.1 %
Loss ratio
65.5 %
61.0 %
Expense ratio
33.8 %
31.9 %
Combined ratio
99.3 %
92.8 %
Return on equity(2)
8.2 %
22.2 %
Adjusted return on equity(1)(2)
11.7 %
22.2 %
Diluted earnings per share
$
0.20
$
0.27
Diluted adjusted earnings per share(1)
$
0.28
$
0.27
__________________ NM - Percentage change is not meaningful. (1)
Non-GAAP financial measure. See “—Reconciliation of Non-GAAP
Financial Measures” for a reconciliation of the non-GAAP financial
measures to their most directly comparable U.S. GAAP measures. (2)
For the three months ended June 30, 2024 and 2023, net income and
adjusted net income are annualized to arrive at return on equity
and adjusted return on equity.
Condensed Consolidated Balance Sheets
June 30, 2024
December 31, 2023
($ in thousands, except share
data)
Assets
Investments
Fixed maturity securities, available for
sale, at fair value (amortized cost of $721,782 and $569,013,
respectively)
$
706,199
$
554,624
Short-term investments, at amortized cost,
which approximates fair value
12,712
8,824
Total investments
718,911
563,448
Cash and cash equivalents
180,324
118,070
Restricted cash and cash equivalents
18,494
1,698
Accrued investment income
6,728
4,660
Premium balances receivable
69,495
38,817
Reinsurance recoverable
192,025
139,389
Prepaid reinsurance premiums
133,992
116,732
Deferred policy acquisition costs
24,564
19,407
Property and equipment, net
7,481
7,601
Income taxes receivable
1,320
1,107
Deferred tax assets, net
17,071
14,229
Other assets
24,768
2,701
Total assets
$
1,395,173
$
1,027,859
Liabilities
Reserve for losses and loss adjustment
expenses
$
587,905
$
431,186
Unearned premiums
391,802
344,704
Reinsurance balances payable
45,767
40,440
Income taxes payable
29
42
Accrued expenses
11,287
14,900
Other liabilities
18,472
4,510
Total liabilities
1,055,262
835,782
Commitments and contingencies (Note
13)
Mezzanine equity
Performance stock units
46
—
Stockholders' equity
Common stock
327
240
($0.01 par value; 400,000,000 shares
authorized, 32,658,823 and 24,000,000 shares issued and outstanding
at June 30,2024 and December 31,2023, respectively)
Additional paid-in capital
314,636
178,543
Accumulated other comprehensive loss
(12,309)
(11,372)
Retained earnings
37,211
24,666
Total stockholders' equity
339,865
192,077
Total mezzanine equity and
stockholders' equity
339,911
192,077
Total liabilities, mezzanine equity and
stockholders' equity
$
1,395,173
$
1,027,859
Gross Written Premiums
The following table presents gross written premiums by
underwriting division for the three months ended June 30, 2024 and
2023:
Three Months ended June
30,
2024
% of Total
2023
% of Total
$ Change
% Change
($ in thousands, except
percentages)
Casualty
$
114,233
65.1 %
$
63,890
54.7 %
$
50,343
78.8 %
Professional Liability
44,397
25.3 %
41,302
35.4 %
3,095
7.5 %
Healthcare
16,909
9.6 %
11,550
9.9 %
5,359
46.4 %
Gross written premiums
$
175,539
100.0 %
$
116,742
100.0 %
$
58,797
50.4 %
Loss Ratio
The following table summarizes current and prior accident loss
ratios for the three months ended June 30, 2024 and 2023:
Three Months Ended June
30,
2024
2023
Net Losses and Loss Adjustment
Expenses
% of Net Earned
Premiums
Net Losses and Loss Adjustment
Expenses
% of Net Earned
Premiums
($ in thousands, except
percentages)
Current accident year
$
59,018
65.5 %
$
37,148
60.5 %
Prior accident year reserve
development
—
— %
261
0.4 %
Total
$
59,018
65.5 %
$
37,409
61.0 %
Expense Ratio
The following table summarizes the components of our expense
ratio for the three months ended June 30, 2024 and 2023:
Three Months Ended June
30,
2024
2023
Expenses
% of Net Earned
Premium
Expenses
% of Net Earned
Premium
($ in thousands, except
percentages)
Net acquisition costs
$
7,582
8.4 %
$
4,960
8.1 %
Operating expenses
22,855
25.4 %
14,616
23.8 %
Total expense ratio
$
30,437
33.8 %
$
19,576
31.9 %
Net Investment Income
The following table summarizes the sources of net investment
income for the three months ended June 30, 2024 and 2023:
Three Months Ended June
30,
2024
2023
($ in thousands)
U.S. government and government agency
$
3,836
$
656
State and municipal
388
388
Commercial mortgage-backed securities
468
363
Residential mortgage-backed securities
1,920
246
Asset-backed securities
(33)
894
Corporate
1,071
893
Short-term investments
103
208
Cash and cash equivalents
1,204
511
Gross investment income
8,957
4,159
Investment expenses
(180)
(111)
Net investment income
$
8,777
$
4,048
Reconciliation of Non-GAAP Financial Measures
This earnings release contains certain financial measures that
are not presented in accordance with generally accepted accounting
principles in the United States (“U.S. GAAP”). We use these
non-GAAP financial measures when planning, monitoring and
evaluating our performance. Management believes that each of the
non-GAAP financial measures described below provides useful insight
into our underlying business performance.
- Adjusted net income is defined as net income excluding the
impact of net realized investment gains, non-operating expenses,
foreign exchange (gains) losses, and certain strategic initiatives.
Adjusted net income excludes the impact of certain items that may
not be indicative of underlying business trends, operating results,
or future outlook, net of tax impact. We calculate the tax impact
only on adjustments which would be included in calculating our
income tax expense using the estimated tax rate at which we
received a deduction for these adjustments.
- Adjusted return on equity is defined as adjusted net income as
a percentage of average beginning and ending mezzanine equity and
stockholders’ equity.
- Diluted adjusted earnings per share is defined as adjusted net
income divided by the weighted average common shares outstanding
for the period, reflecting the dilution that may occur if equity
base awards are converted into common stock equivalents as
calculated using the treasury stock method.
You should not rely on these non-GAAP financial measures as a
substitute for any U.S. GAAP financial measure. While we believe
that these non-GAAP financial measures are useful in evaluating our
business, this information should be considered supplemental in
nature and not as a replacement for or superior to the comparable
U.S. GAAP measures. In addition, other companies, including
companies in our industry, may calculate such measures differently,
which reduces their usefulness as comparative measures.
Adjusted net income
Adjusted net income for the three months ended June 30, 2024 and
2023 reconciles to net income as follows:
Three Months Ended June
30,
2024
2023
Before income taxes
After income taxes
Before income taxes
After income taxes
($ in thousands)
Income as reported
$
7,410
$
5,533
$
8,460
$
6,555
Adjustments:
Net realized investment gains
(2)
(2)
—
—
Non-operating expenses
1,481
1,481
—
—
Foreign exchange (gains) losses
(4)
(4)
8
8
Strategic initiatives(1)
1,496
1,496
—
—
Tax impact
—
(624)
—
(2)
Adjusted net income
$
10,381
$
7,880
$
8,468
$
6,561
___________________
(1) Strategic initiatives for the three
months ended June 30, 2024 represents costs incurred to set up our
Baleen Specialty division, which is recorded in operating expenses
within the Condensed Consolidated Statements of Income and
Comprehensive Income. The costs incurred primarily represent
expenses to implement the new platform and processes supporting the
Baleen Specialty division. See “Business— Our Strategy”
Adjusted return on equity
Adjusted return on equity for the three months ended June 30,
2024 and 2023 reconciles to return on equity as follows:
Three Months Ended June
30,
2024
2023
($ in thousands, except
percentages)
Numerator: Adjusted net income(1)
31,519
26,245
Denominator: Average mezzanine equity and
stockholders' equity
270,551
118,144
Adjusted return on equity
11.7 %
22.2 %
___________________
(1) For the three months ended June 30,
2024, and 2023, net income and adjusted net income are annualized
to arrive at return on equity and adjusted return on equity.
Diluted adjusted earnings per share
Diluted adjusted earnings per share for the three months ended
June 30, 2024 and 2023 reconciles to diluted earnings per share as
follows:
Three Months Ended June
30,
2024
2023
($ in thousands, except share and
per share data)
Numerator: Adjusted net income
$
7,880
$
6,561
Denominator: Diluted weighted average
shares outstanding
27,771,108
24,000,000
Diluted adjusted earnings per
share
$
0.28
$
0.27
About Bowhead Specialty Holdings Inc.
Bowhead Specialty is a growing specialty insurance business
providing casualty and professional liability insurance products.
We were founded and are led by industry veteran Stephen Sills. The
team is composed of highly experienced and respected industry
veterans with decades of individual, successful underwriting and
management experience. We focus on providing “craft” solutions in
our specialty lines and classes of business that we believe require
deep underwriting and claims expertise in order to produce
attractive financial results.
We pride ourselves on the quality and experience of our people,
who are committed to exceeding our partners’ expectations through
excellent service and expertise. Our collaborative culture spans
all functions of our business and allows us to provide a
consistent, positive experience for all of our partners.
Conference Call
The Company will host a conference call to discuss its results
on the same day, Tuesday, August 6, 2024, beginning at 8:30 a.m.
Eastern Time. Interested parties may access the conference call
through a live webcast, which can be accessed via this link or by
visiting the Company’s Investor Relations website, or by dialing
(866) 682-6100 (toll-free) or (862) 298-0702 (international).
Please join the live webcast or dial in at least 10 minutes before
the start of the call.
A replay of the event webcast will be available on the company’s
Investor Relations website for one year following the call.
Forward-Looking Statements
This press release contains forward-looking statements. All
statements other than statements of historical facts contained in
press release are forward-looking statements. In some cases,
forward-looking statements can be identified by terms such as
"anticipates," "believes," "estimates," "expects," "intends,"
"plans," "predicts," "projects," "seeks," "future," "outlook,"
"prospects" "will," "would," "should," "could," "may," "can have"
or similar words. Forward-looking statements involve risks and
uncertainties that could cause actual results to differ materially
from those contemplated by the forward-looking statements. These
risks include those described under the caption "Risk Factors" in
the Company's registration statement on Form S-1, Quarterly Report
on Form 10-Q and other filings made with the Securities and
Exchange Commission. Forward-looking statements speak only as of
the date of this press release and the Company does not undertake
any obligation to update or revise any forward-looking information
to reflect changes in assumptions, the occurrence of unanticipated
events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240806859625/en/
Investor Relations: Shirley Yap, Head of Investor
Relations investorrelations@bowheadspecialty.com
Bowhead Specialty (NYSE:BOW)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Bowhead Specialty (NYSE:BOW)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024